Shares

GSK Share Price Undervalued, Says Research Firm Berenberg

Published by
Written By: Eno Ikenna Eteng
Share
    Summary:
  • The GSK share price target has been cut by analysts at Berenberg, even though the research firm still maintains a BUY recommendation.

The GSK share price is trading lower today, despite the call by analysts at Berenberg that the stock is undervalued. However, the Berenberg analysts think there will be a price drop before the stock takes off, which informs their decision to cut the target price from 1625p to 1540p. 

GSK has had several suitors for its Consumer Healthcare division. The valuation of this division could make any potential buyout the most expensive in history, which informs the “Buy” recommendation of Berenberg. However, the reduced price target gives the bears some room to act before any takeover for this division is completed.

The GSK share price is currently trading lower by 0.5%.

GSK Share Price Outlook

The intraday decline is pushing the GSK share price towards the 1382.6 support level. A breakdown of this level is required for 1359.0 to become available as additional support. This move also challenges the channel’s lower border, and a continued decline breaks down the channel and makes 1323.2 available. 

On the flip side, a bounce on the 1382.6 support could allow the bulls to aim at the channel’s upper border. A breakout here would need to take out 1415.0, which makes 1432.0 and 1450.0 likely candidates for additional destinations to the north. 

GSK: Daily Chart

Follow Eno on Twitter.

This post was last modified on %s = human-readable time difference 13:54

Written By: Eno Ikenna Eteng

Eno's work as a technical analyst and author since 2009 is well recognized in the industry and on several freelance platforms. He is also a member of the prestigious UK Society of Technical Analysts and a top-ranked participant in the Basic Investment Banking and Asset Management simulations with Amplify Trading.

Published by
Written By: Eno Ikenna Eteng